Transaction · 0001213900-26-060632
AAPGASCENTAGE PHARMA GROUP INTERNATIONAL
Zhai Yifan
Zhai Yifan, CMO, reported a transaction classified as grant at ASCENTAGE PHARMA GROUP INTERNATIONAL involving 298194.000000 shares for an estimated $0.00. Reported holdings after the transaction were 298194.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
grantSEC transaction code ACMO
- Trade date
- May 20, 2026
- Filing date
- May 22, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
AAPG price since this filing
Daily closing prices, with the filing date and available return windowsAAPG · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +25.5%1w ago +1.8%1d ago -9.6%
Returns since7d -4.8%30d -18.5%90d -17.6%180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0001213900-26-060632 Options
- Transaction date
- May 20, 2026 Filed May 22, 2026, 08:44 PM · 2d delay
- Shares
- 298,194 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 298,194 sh Indirect · By Spouse
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Large Holdings Increase
Filing-only score
-12 points
Compact filing score computed from stored Form 4 facts. Version v1.
Mixed or weak signal
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
Chief Medical Officer
Officer YesDirector No10% NoOther No
Footnotes & amended
- F1F2F3(3 footnotes)
Shares held by Dajun Yang Dynasty Trust, of which the Reporting Person's spouse is the investment advisor. The Reporting Person disclaims beneficial ownership over such securities except to the extent…
- F4
Each restricted stock unit (the "RSUs") represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on November 26, 2026, 2027, 2028…
- F5
The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date.
- F6
The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal…
- F7
The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal…
- F8
The RSUs vested on 05/21/2026 and had no expiration date.
- F9
Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026.
- F10
Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026.
Related transactions
Same SEC filing0 other transactions
Recent company activity
AAPG0 recent txs